Holen Sie sich die Stockscreener-App
66.44
0.48%
0.32
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CCI?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$66.12
Offen:
$66.29
24-Stunden-Volumen:
2.95M
Relative Volume:
0.83
Marktkapitalisierung:
$28.27B
Einnahmen:
$4.21B
Nettoeinkommen (Verlust:
$-51.00M
KGV:
13.51
EPS:
4.9176
Netto-Cashflow:
$2.73B
1W Leistung:
-2.06%
1M Leistung:
-11.86%
6M Leistung:
-21.63%
1J Leistung:
-30.40%
1-Tages-Spanne:
$65.83
$68.17
1-Wochen-Bereich:
$65.68
$68.17
52-Wochen-Spanne:
$65.68
$100.50
Cigna Group Stock (CCI) Company Profile
Firmenname
Cigna Group
Sektor
Branche
Telefon
(713) 570-3000
Adresse
8020 KATY FREEWAY, HOUSTON, TX
Compare CCI vs UNH, CVS, ELV, CI, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CCI
Cigna Group
|
66.44 | 28.86B | 4.21B | -51.00M | 2.73B | 4.9176 |
UNH
Unitedhealth Group Inc
|
371.90 | 327.80B | 450.13B | 14.91B | 23.62B | 15.55 |
CVS
Cvs Health Corp
|
86.46 | 113.99B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
386.43 | 85.90B | 201.11B | 4.95B | 6.29B | 22.50 |
CI
Cigna Group
|
270.53 | 71.88B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
388.36 | 47.78B | 137.20B | 1.15B | 1.27B | 9.3439 |
Cigna Group Stock (CCI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-31 | Eingeleitet | Truist | Hold |
| 2026-03-23 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2026-03-05 | Eingeleitet | Bernstein | Outperform |
| 2026-01-05 | Herabstufung | New Street | Buy → Neutral |
| 2025-12-01 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-10-02 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-09-22 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-08-19 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2025-07-24 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-05-19 | Fortgesetzt | BofA Securities | Buy |
| 2025-03-20 | Fortgesetzt | BofA Securities | Neutral |
| 2025-03-17 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2025-03-17 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2025-03-14 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-03-14 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2025-03-14 | Hochstufung | UBS | Neutral → Buy |
| 2025-01-27 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2025-01-13 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-01-02 | Herabstufung | Jefferies | Buy → Hold |
| 2024-12-10 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-04-19 | Herabstufung | Argus | Buy → Hold |
| 2024-01-19 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
| 2023-12-14 | Eingeleitet | HSBC Securities | Hold |
| 2023-12-05 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-10-16 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-13 | Eingeleitet | Scotiabank | Sector Perform |
| 2023-08-10 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-08-02 | Eingeleitet | Argus | Buy |
| 2023-07-13 | Eingeleitet | BMO Capital Markets | Underperform |
| 2023-03-30 | Hochstufung | MoffettNathanson | Market Perform → Outperform |
| 2023-01-23 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-01-12 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-06-30 | Hochstufung | Jefferies | Hold → Buy |
| 2022-06-29 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-06-02 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2022-01-28 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2022-01-10 | Herabstufung | Jefferies | Buy → Hold |
| 2022-01-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-10-19 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-10-13 | Fortgesetzt | Wolfe Research | Underperform |
| 2021-09-10 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2021-05-04 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2021-04-12 | Fortgesetzt | Jefferies | Buy |
| 2021-03-26 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-19 | Eingeleitet | Wolfe Research | Peer Perform |
| 2021-03-18 | Eingeleitet | Wolfe Research | Outperform |
| 2021-01-14 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-12-11 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-10-26 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-08-20 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-07-15 | Eingeleitet | Barclays | Overweight |
| 2020-06-05 | Fortgesetzt | Deutsche Bank | Hold |
| 2020-05-22 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2020-04-28 | Eingeleitet | Credit Suisse | Neutral |
| 2019-08-14 | Bestätigt | BofA/Merrill | Buy |
| 2019-08-01 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2019-04-12 | Herabstufung | Guggenheim | Buy → Neutral |
| 2019-04-11 | Herabstufung | UBS | Buy → Neutral |
| 2019-03-19 | Bestätigt | BofA/Merrill | Buy |
| 2019-03-19 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2019-02-12 | Herabstufung | Macquarie | Outperform → Neutral |
| 2019-01-14 | Herabstufung | Goldman | Buy → Neutral |
| 2019-01-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-12-03 | Herabstufung | MoffettNathanson | Buy → Neutral |
| 2017-10-16 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2017-06-12 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2017-04-11 | Hochstufung | Guggenheim | Neutral → Buy |
Alle ansehen
Cigna Group Aktie (CCI) Neueste Nachrichten
FBT Gibbons Beats DQ Bid In Suit Over Cigna Payments - Law360
Cigna Better Positioned to Meet Long-Term EPS Growth Targets, RBC Says - marketscreener.com
UBS reiterates Cigna stock buy rating on 2026-2030 outlook By Investing.com - Investing.com Canada
Cigna rated 'Strong Buy' with strong Q2 results and 10-14% EPS growth target through 2030. - Pluang
Cigna: Deeply Undervalued With Expected Double-Digit EPS Growth Ahead - Seeking Alpha
Jefferies Adjusts Price Target on Cigna Group to $288 From $307, Keeps Hold Rating - marketscreener.com
The Cigna Group (CI) Stock Forecasts - Yahoo Finance
The Cigna Group Unveils Lead to One and $3 Billion Plan at Investor Day - Grit Daily News
Crown Castle Announces Third Quarter 2026 Earnings Conference Call Details - GlobeNewswire Inc.
Cigna Group (CI), What Is Behind The Fresh Attention? - Yahoo Finance
After Investment Year in 2026, Cigna Aims to Reaccelerate Profit Growth - Morningstar
HCA Houston and Cigna locked in new contract dispute with deal set to expire - The Business Journals
Cigna Sets Long-Term Goals, Unveils 2030 Modernization Strategy - Benzinga
Cigna options flow turns bullish even as technicals signal sell - Investing.com
Cigna, Fla. Atty Resolve $21M Claim In Ch. 7 Case - Law360
What Cigna Group (CI)'s $3 Billion Modernization Plan Means For Shareholders - Simply Wall Street
Cigna Reaffirms 2026 Outlook, Targets Complex Care and AI-Driven Growth - Yahoo Finance
The Cigna Group (CI) Analyst/Investor DaySlideshow (NYSE:CI) 2026-09-30 - Seeking Alpha
Cigna Group expects $3B in savings driven by AI, automation - Modern Healthcare
Cigna Outlines $3 Billion Modernization, Productivity Initiative - 富途牛牛
The Cigna Group (CI) Reaffirms 2026 Outlook and Sets 10-14% Long-Term Adjusted EPS Growth Target at Investor Day - GuruFocus
Cigna launches $3B cost-savings initiative focused on AI, automation - Hartford Business Journal
Cigna Stock: Specialty Drug Growth Takes Focus at Investor Day - Barron's
Cigna Group (CI) Reaffirms FY26 Guidance Amid Investor Day Insig - GuruFocus
Cigna (CI) Unveils $3 Billion AI Initiative, Reaffirms 2026 Guid - GuruFocus
Cigna expects $3 billion in cost savings by 2030 - reuters.com
Cigna sets aside $3B to boost performance (CI:NYSE) - Seeking Alpha
Will New CEO’s Specialty Pharmacy Focus Reshape Cigna Group’s (CI) Evernorth and Signature Narrative? - Yahoo Finance
Cigna Group stock tracks new 2030 earnings targets - AD HOC NEWS
Cigna Group reaffirms 2026 outlook at investor day - StreetInsider
Cigna unveils $3B modernization plan and targets 10-14% EPS growth through 2030 with new personalization strategy - Pluang
The Cigna Group reaffirms 2026 guidance, unveils "Lead to One" and $3B modernization plan - TradingView
The Cigna Group Hosts 2026 Investor Day Introduces "Lead To One" To Drive Durable Growth Through Complex Care Leadership And Differentiated Capabilities - TradingView
Cigna To Ramp Up Investments In Specialty Pharmacy And Complex Care - currently.att.yahoo.com
Cigna unveils $3B productivity initiative, including use of AI - Healthcare Dive
Have Cigna insurance? Your St. David’s care could cost more starting Thursday - Austin American-Statesman
Cigna, OpenAI partner on AI-driven personalized cancer care - TechTarget
Cigna Group stock trades flat as Investor Day nears - AD HOC NEWS
Cigna Group stock outperforms competitors on strong trading day - MarketWatch
Cigna and OpenAI collaborate on complex condition support - Healthcare Finance News
Cigna Group and OpenAI Partner to Support Patients With Complex Conditions - Digital Health News
The Cigna Group stock falls 1.03 percent after Q2 beat - AD HOC NEWS
Cigna Group (CI) Looks 58% Undervalued, Is The Recent Pullback A Buying Opportunity? - simplywall.st
Cigna Group stock slips 4.3 percent ahead of the open - AD HOC NEWS
Cigna Group, OpenAI team up to support patients with complex conditions - Fierce Healthcare
Cigna Group stock underperforms Thursday when compared to competitors - MarketWatch
UHC, Cigna and Centene Sign On to New National Shared Credentialing Program - MedCity News
Cigna Group, OpenAI partner to expand complex condition care - Modern Healthcare
The Cigna Group (CI) Stock Price, News, Quote & History - Yahoo! Finance Canada
Cigna Group stock slips 0.32 percent ahead of the open - AD HOC NEWS
Cigna Group stock underperforms Wednesday when compared to competitors - MarketWatch
Finanzdaten der Cigna Group-Aktie (CCI)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):